ERBB2 and breast cancer: The Prosigna PAM-50 gene signature is based on expression levels of 50 genes used to classify breast cancers into one of the four breast cancer intrinsic subtypes (Luminal A, Luminal B, HER2-enriched or Basal-like) originally described in 2000 [61].